Cellectis to Report Fourth Quarter and Year-End 2022 Financial Results on March 8, 2023
Published on March 01, 2023
March 1st, 2023 - New York, NY - Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced that it will report financial results for the fourth quarter and year-end 2022 ending December 31st, 2022, on Wednesday, March 8, 2023, after the close of the US market.
The announcement will be followed by a conference call and live audio webcast on Thursday, March 9, 2023, at 8:00 AM ET / 2:00 PM CET. The call will include the Company’s fourth quarter results, year-end results, and an update on business activities. Details for the call are as follows:
Call Me Link: https://callme.viavid.com/viavid/?callme=true&passcode=13727032&h=true&info=company-email&r=true&B=6
Webcast Link: https://viavid.webcasts.com/starthere.jsp?ei=1598389&tp_key=25a6baeb0f